» Articles » PMID: 39701495

Management of Asthma in Pregnancy

Overview
Journal Clin Med (Lond)
Specialty General Medicine
Date 2024 Dec 19
PMID 39701495
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is the most common chronic disease to affect pregnant women and can have a significant effect on pregnancy outcomes, with increased rates of preterm birth, premature delivery and caesarean section observed if poorly controlled. Pregnancy can also influence asthma control. Prescribing in pregnancy causes anxiety for patients and healthcare professionals and can result in alteration or undertreatment of asthma. Good asthma control with prompt and adequate management of exacerbations is key to reducing adverse pregnancy outcomes for both mother and fetus. The majority of asthma treatment can be continued as normal in pregnancy and there is emerging evidence of the safety of biologic medications also. This article aims to summarise the current evidence about asthma in pregnancy and guide the appropriate management of this population.

Citing Articles

Clinical inertia - It is imperative to avoid delays in managing common conditions in pregnancy.

Banerjee A, Banerjee D, Saravanan P, Saravanan P Clin Med (Lond). 2025; 25(1):100286.

PMID: 39824391 PMC: 11803205. DOI: 10.1016/j.clinme.2025.100286.

References
1.
Palmeira P, Quinello C, Silveira-Lessa A, Zago C, Carneiro-Sampaio M . IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012; 2012:985646. PMC: 3251916. DOI: 10.1155/2012/985646. View

2.
Grosso A, Locatelli F, Gini E, Albicini F, Tirelli C, Cerveri I . The course of asthma during pregnancy in a recent, multicase-control study on respiratory health. Allergy Asthma Clin Immunol. 2018; 14:16. PMC: 5902995. DOI: 10.1186/s13223-018-0242-0. View

3.
Middleton P, Gade E, Aguilera C, Mackillop L, Button B, Coleman C . ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J. 2019; 55(2). DOI: 10.1183/13993003.01208-2019. View

4.
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A . Physiological changes in pregnancy. Cardiovasc J Afr. 2016; 27(2):89-94. PMC: 4928162. DOI: 10.5830/CVJA-2016-021. View

5.
Namazy J, Cabana M, Scheuerle A, Thorp Jr J, Chen H, Carrigan G . The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol. 2014; 135(2):407-12. DOI: 10.1016/j.jaci.2014.08.025. View